other material
confidence high
sentiment neutral
materiality 0.70
X4 Pharmaceuticals secures $40M equity line with Lincoln Park Capital
X4 Pharmaceuticals, Inc
- Company may sell up to $40M of common stock to Lincoln Park over 24 months.
- Purchase price set at 97% of the lower of lowest or 3-day-average closing price.
- Regular purchases capped at 30k–60k shares per day based on stock price thresholds.
- Issued 137,099 commitment shares to Lincoln Park as a fee for entering the agreement.